title: [Metabolically neutral therapy of hypertension. An open, multicenter, prospective long-term study of the tolerance, safety and effectiveness of urapidil].
authors.forename: H
authors.initials: H
authors.lastname: Liebau
authors.forename: W
authors.initials: W
authors.lastname: Wurst
authors.forename: I
authors.initials: I
authors.lastname: Harder
authors.forename: P
authors.initials: P
authors.lastname: Solleder
mesh_terms: D000959:Antihypertensive Agents / Q000627:therapeutic use*; D001786:Blood Glucose / Q000378:metabolism; D002986:Clinical Trials as Topic; D005260:Female; D006801:Humans; D006973:Hypertension / Q000188:drug therapy*; D008055:Lipids / Q000097:blood; D008134:Long-Term Care; D008297:Male; D008875:Middle Aged; D010879:Piperazines / Q000627:therapeutic use*; D011446:Prospective Studies
chemical_list: D000959:Antihypertensive Agents; D001786:Blood Glucose; D008055:Lipids; D010879:Piperazines; C015568:urapidil
vernacular_title: Stoffwechselneutrale Hochdrucktherapie. Offene, multizentrische, prospektive Langzeitprüfung von Verträglichkeit, Sicherheit und Wirksamkeit von Urapidil.